Last reviewed · How we verify
NCT03208699: EXPALI
EXPert System, ALImentary
trial in Eating Disorder Symptom in 256 participants. Completed in 31 December 2015.
1 October 2015
Quick facts
| Lead sponsor | Marie-Pierre TAVOLACCI |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 256 |
| Start date | 1 October 2015 |
| Primary completion | 1 October 2015 |
| Estimated completion | 31 December 2015 |
Conditions studied
- Eating Disorder Symptom — all drugs for Eating Disorder Symptom →
Sponsor
Marie-Pierre TAVOLACCI
Who can join
18 and older, any sex, with Eating Disorder Symptom. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Eating disorders (ED) are often undetected in the general population resulting in delayed treatment. The SCOFF questionnaire has been validated for eating disorders screening in primary care, but does not identify the type of eating disorder. Objective: Investigators evaluated the performance of a clinical algorithm (ExpaliTM) combining answers to SCOFF questionnaire with Body Mass Index (BMI) to identify four Broad Categories of ED derived from DSM-5. Design: Clinical algorithm (ExpaliTM) was developped from 104 combinations of BMI levels and answers to five SCOFF questions. Two senior ED specialists allocated each combination to one of the four Broad Categories of ED (DSM-5 diagnostics): restrictive disorder (anorexia nervosa typical, atypical and restrictive food intake disorders), bulimic disorder (typical and with low frequency or duration), hyperphagic disorder (binge eating disorders typical and with low frequency or duration) and other specified ED. The performance of ExpaliTM was evaluated on data from patients referred to the Nutrition Department including a precise DSM-5 diagnosis of ED, a positive SCOFF test (at least 2 "yes" answers) and BMI. Sensitivity, specificity values with a 95% confidence interval (95% CI) and Youden index were calculated for each category.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03208699
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eating Disorder Symptom
Currently open trials in the same condition.
- NCT06551974 — INTERconNEcT-Eds: a Guided Self-help Mobile App to Improve Outcome in Eating Disorders · NA · recruiting
- NCT03488966 — Mindfulness Based Eating Awareness Training for Bariatric Surgery Patients · NA · active not recruiting
Other Marie-Pierre TAVOLACCI trials
Trials by the same sponsor.
- NCT03204214 — Binge Drinking And Addiction : Case-Control Study in Hospital · unknown
- NCT03218670 — Your Health in On Click · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03208699 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marie-Pierre TAVOLACCI
- Last refreshed: 6 July 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03208699.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing